Product Program year 2020 Source: CMS Open Payments

Resolute

Device Stents

Open in the dashboard

General payments

$2,707,113

16,586 payments

Research payments

$3,257,888

208 payments

Through program year 2020, $2,707,113 in general payments and $3,257,888 in research payments were reported against Resolute (Stents).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $881,700 6,674
2020 Research $1,443,209 111
2019 General $1,825,414 9,912
2019 Research $1,814,679 97

Breakdown

Who paid General payments · program years 2019–2020
  1. Medtronic Vascular, Inc. $2,704,558 16,532 payments
  2. Medtronic, Inc. $2,556 54 payments
Top recipients General payments · program year 2020
  1. Gary Mintz Washington, DC $56,250 6% · 2 payments
  2. Emmanouil Brilakis Interventional Cardiology · Minneapolis, MN $27,058 3% · 19 payments
  3. Robert Riley Interventional Cardiology · Bellevue, WA $18,919 2% · 9 payments
  4. David Kandzari Interventional Cardiology · Atlanta, GA $15,725 2% · 9 payments
  5. Wissam Jaber Interventional Cardiology · Atlanta, GA $14,216 2% · 12 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Interventional Cardiology Internal Medicine $530,696 67% · 992 practitioners
  2. Cardiovascular Disease Internal Medicine $231,030 29% · 613 practitioners
  3. Clinical Cardiac Electrophysiology Internal Medicine $8,913 1% · 53 practitioners
  4. Anatomic Pathology Pathology $8,134 1% · 1 practitioner
  5. Internal Medicine $4,955 <1% · 43 practitioners

The top 5 of 40 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Ohio $80,970 9% · 42 recipients
  2. District of Columbia $73,336 8% · 8 recipients
  3. New York $72,666 8% · 158 recipients
  4. California $64,195 7% · 104 recipients
  5. Texas $59,270 7% · 212 recipients

The top 5 of 51 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

16,586 general · 208 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record